| Literature DB >> 32576161 |
Remi L Gratacap1, Tim Regan2, Carola E Dehler3, Samuel A M Martin3, Pierre Boudinot4, Bertrand Collet4, Ross D Houston5.
Abstract
BACKGROUND: Genome editing is transforming bioscience research, but its application to non-model organisms, such as farmed animal species, requires optimisation. Salmonids are the most important aquaculture species by value, and improving genetic resistance to infectious disease is a major goal. However, use of genome editing to evaluate putative disease resistance genes in cell lines, and the use of genome-wide CRISPR screens is currently limited by a lack of available tools and techniques.Entities:
Keywords: CHSE; CRISPR; Disease resistance; Gene editing; Lentivirus; Salmon
Mesh:
Substances:
Year: 2020 PMID: 32576161 PMCID: PMC7310381 DOI: 10.1186/s12896-020-00626-x
Source DB: PubMed Journal: BMC Biotechnol ISSN: 1472-6750 Impact factor: 2.563
Fig. 1CHSE salmon cells are efficiently transduced with lentivirus. a Efficient transduction of CMV:EGFP in CHSE Chinook salmon cell line by lentivirus. Salmon cells were spinfected at 22 °C with neat lentivirus supernatant for 2 h at 1000 x g. The cells were incubated for 24 h and the media was replaced. After 2 weeks of expansions, fluorescence was recorded by flow cytometry using CHSE wt (not transduced) as control. Split histogram of control cells (top) and pLenti-GFP transduced CHSE with optimal conditions (bottom). Data were normalised to Mode (relative percentage of cells rather than number). b Representative image of CHSE cells 8 days post transduction with pLenti-GFP. Differential Interference Contrast (top) and GFP (bottom) channels are represented. Arrows point to GFP negative cells. Scale bar 20 μm. c-d Different conditions of the optimisation protocol with optimal conditions in purple. c, Incubation temperature and spinfection influences the efficiency of transduction. Cells were transduced with neat lentivirus supernatant, spinfected for 2 h at 1000 x g (or not) and incubated at 17 °C (17), 22 °C (22) or heat shocked for 4 h at 28 °C followed by 22 °C for 2 weeks (28–22) until flow cytometry. d, Incubation of the cells with the virus for 4 h reduces the efficiency of transduction. CHSE were transduced with neat lentivirus dose at different temperatures and media was changed after 4 or 24 h
Fig. 2The genome of CHSE-EC salmon cells is efficiently edited with lentivirus. a-d Efficient editing of EGFP in CHSE-EC Chinook salmon cell line by lentivirus. CHSE-EC cells were spinfected for 2 h at 1000 g with neat (Hi) and 1:10 dilution (Lo) of lentivirus supernatant and incubated at 22 °C. After 2 weeks of expansion, puromycin was added to the Lo group (0.25 μg / mL, for 1 week, Lo + Puro). Fluorescence was imaged by epifluorescence microscopy (a) and recorded flow cytometry (b) using CHSE wt and CHSE-EC (not transduced) as controls. Split histogram of fluorescence and corresponding proportion histogram of control cells (top and bottom) and CHES-EC transduced with high and low concentration (with and without puromycin treatment) lentivirus supernatant. Scale bar in a represents 20 μm. c Genome editing efficiency in CHSE-EC by Sanger sequencing of PCR amplified product of the target loci, estimated by ICE analysis. d Detail of indels frequency in EGFP edited Hi group (from panel c), estimated by ICE analysis. Purple dot denotes the unedited sequence (0 bp). e-f Efficient editing of RIG-I in CHSE-EC. e Genome editing of the RIG-I gene in CHSE-EC. CHSE-EC cells were transduced similar to EGFP targeting (Puro-) and selected with puromycin (Puro+) and efficiency estimated by ICE analysis of Sanger sequencing chromatogram from the PCR amplified target region. f Detail of indels frequency in RIG-I edited Puro- group (from panel e), estimated by ICE analysis. Purple dot denotes the unedited sequence (0 bp)
Primers used in the study (from IDT or Sigma). gRNA target sequence underlined
| Primers name | Primer sequence | Annealing temp (°C) |
|---|---|---|
| EGFP_Fw_gRNA | caccgggcgaggagctgttcaccg | N/A |
| EGFP_Rv_gRNA | aaaccggtgaacagctcctcgccc | N/A |
| EGFP_Fw_seq (CMV-F) | cgcaaatgggcggtaggcgtg | 63.5 |
| EGFP_Rv_seq | gctgaagcactgcacgccgt | |
| U6_Fw_Seq (hU6-F) | gagggcctatttcccatgatt | N/A |
| Otsha_RIG-I_Fw_gRNA | caccgcgttccagaggttgcagag | N/A |
| Otsha_RIG-I_Rv_gRNA | aaacctctgcaacctctggaacgc | N/A |
| Otsha_RIG-I_Fw_seq | aagtgtcaaagtacagcaattctagc | 64 |
| Otsha_RIG-I_Rv_seq | cttccagggcatctagcagg | |
| Otsha_RIG-I_OffT1_Fw_seq Offfasasfafqfaf’fI_Off1_Fw_sec | tgttgatctctgccttgcac | 64 |
| Otsha_RIG-I_OffT1_Rv_seq | tatcccaccttggttgcttc | |
| Otsha_RIG-I_OffT2_Fw_sec | cggacaacaggccattagat | 64 |
| Otsha_RIG-I_OffT2_Rv_sec | tggcgtactgcactagcatc |
Plasmids used in this study (from Addgene, USA)
| Plasmid construct | Plasmid name (Addgene) | Plasmid number (Addgene) |
|---|---|---|
| pLenti CMV:EGFP_PGK:Puro | pLenti CMV GFP Puro (658–5) | 17,448, [ |
| pLenti hU6:gRNA_PKG:Puro | pKLV2-U6gRNA5(BbsI)-PGKpuro2ABFP-W | 67,974, [ |